Outside of intestinal aspects of IFNγ, when dairy cows were pre-treated with recombinant IFNγ and challenged intra-mammary with E. coli, animals demonstrated reduced duration of infection and lower clinical scores of mastitis compared to non-treated animals40. Here, IFNG is linked to mastitis.